Formicort-FT Capsule is a combination medication containing Formoterol (6mcg) and Fluticasone Propionate (250mcg), designed for the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol is a long-acting beta2-adrenergic agonist that helps relax the muscles in the airways, improving airflow and making breathing easier. Fluticasone Propionate is a corticosteroid that reduces inflammation and swelling in the airways, preventing asthma attacks and exacerbations of COPD. Together, these components provide both immediate bronchodilation and long-term control of airway inflammation, enhancing respiratory function and reducing symptoms such as wheezing, coughing, and shortness of breath. Formicort-FT Capsule is typically prescribed for patients requiring maintenance treatment to prevent bronchospasm and improve lung function. It is important to use this medication regularly as directed by a healthcare professional, even when symptoms are not present, to achieve optimal control of respiratory conditions. Patients should avoid abrupt discontinuation and consult their doctor if they experience any side effects such as tremors, palpitations, or oral thrush. This medication is not intended for relief of acute bronchospasm and should be used under medical supervision.